Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cisapride poisoning |
Causative agent (attribute) |
True |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental cisapride poisoning |
Causative agent (attribute) |
False |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional cisapride poisoning |
Causative agent (attribute) |
False |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par la cisapride d'intention indéterminée |
Causative agent (attribute) |
False |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cisapride adverse reaction (disorder) |
Causative agent (attribute) |
True |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to cisapride |
Causative agent (attribute) |
False |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cisapride overdose |
Causative agent (attribute) |
True |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental cisapride overdose |
Causative agent (attribute) |
True |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional cisapride overdose |
Causative agent (attribute) |
True |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose de cisapride d'intention indéterminée |
Causative agent (attribute) |
False |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing cisapride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cisapride 10 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cisapride (as cisapride monohydrate) 1 milligram/1 milliliter conventional release oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cisapride 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cisapride 1mg/mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cisapride (as cisapride monohydrate) 1 milligram/1 milliliter conventional release oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental cisapride poisoning |
Causative agent (attribute) |
True |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional cisapride poisoning |
Causative agent (attribute) |
True |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to cisapride |
Causative agent (attribute) |
False |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Cisapride monohydrate |
Is a |
False |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cisapride 10 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cisapride 10 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
True |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cisapride 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cisapride 20 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cisapride 10 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
True |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cisapride 20 mg oral tablet |
Has precise active ingredient |
True |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing cisapride in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cisapride (as cisapride monohydrate) 1 milligram/1 milliliter conventional release oral suspension |
Has basis of strength substance (attribute) |
False |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cisapride monohydrate |
Is modification of (attribute) |
True |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing only cisapride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only cisapride in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to cisapride |
Causative agent (attribute) |
True |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cisapride (as cisapride monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cisapride 1 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cisapride 1 mg/mL oral suspension |
Has precise active ingredient |
True |
Cisapride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |